IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASE: CASE REPORT
EL. Mouhtadi S.,* Filali N., Abahssain H., Harrak S., Mrabti H., Boutayeb S. and Errihani H.
ABSTRACT
The anti-tumour immune response involves a cycle of complex immunological events, in which T lymphocytes play a major role. Cytotoxic T cells lysis tumour cells in collaboration with T lymphocytes with auxiliary functions.
[Full Text Article] [Download Certificate]